loadpatents
name:-0.019150018692017
name:-0.011198997497559
name:-0.0042018890380859
Dedhar; Shoukat Patent Filings

Dedhar; Shoukat

Patent Applications and Registrations

Patent applications and USPTO patent grants for Dedhar; Shoukat.The latest application filed is for "novel sulfonamide compounds for inhibition of metastatic tumor growth".

Company Profile
0.12.16
  • Dedhar; Shoukat - Richmond CA
  • Dedhar; Shoukat - North Vancouver CA
  • Dedhar; Shoukat - Vancouver CA
  • Dedhar, Shoukat - Ontario CA
  • Dedhar; Shoukat - North Vancouver B.C. CA
  • Dedhar; Shoukat - Richmond Hill Ontario CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Carbonic anhydrase IX-related markers and use thereof
Grant 10,195,174 - McDonald , et al. Fe
2019-02-05
Sulfonamide compounds for inhibition of metastatic tumor growth
Grant 9,962,398 - Supuran , et al. May 8, 2
2018-05-08
Novel Sulfonamide Compounds For Inhibition Of Metastatic Tumor Growth
App 20170007627 - SUPURAN; Claudiu ;   et al.
2017-01-12
Sulfonamide compounds for inhibition of metastatic tumor growth
Grant 9,463,171 - Supuran , et al. October 11, 2
2016-10-11
Carbonic Anhydrase Ix-related Markers And Use Thereof
App 20140303103 - McDonald; Paul C. ;   et al.
2014-10-09
Carbonic Anhydrase Inhibitors With Antimetastatic Activity
App 20140148400 - Supuran; Claudiu ;   et al.
2014-05-29
Biomarkers of cancer metastasis
Grant 8,735,061 - Lou , et al. May 27, 2
2014-05-27
Novel Sulfonamide Compounds For Inhibition Of Metastatic Tumor Growth
App 20130190396 - Supuran; Claudiu ;   et al.
2013-07-25
Biomarkers Of Cancer Metastasis
App 20120301891 - LOU; Yuanmei ;   et al.
2012-11-29
Treatment of inflammatory diseases including psoriasis
Grant 7,863,429 - Dedhar , et al. January 4, 2
2011-01-04
Biomarkers Of Cancer Metastasis
App 20100317533 - LOU; Yuanmei ;   et al.
2010-12-16
Integrin-linked kinase and its uses
Grant 7,655,780 - Dedhar , et al. February 2, 2
2010-02-02
Integrin-linked kinase and its uses
App 20080039419 - Dedhar; Shoukat ;   et al.
2008-02-14
Integrin-linked kinase and its uses
App 20070203326 - Dedhar; Shoukat ;   et al.
2007-08-30
Integrin-linked kinase and its uses
Grant 7,189,802 - Dedhar , et al. March 13, 2
2007-03-13
Antiangiogenic compounds and an assay for inhibitors of cell invasion
App 20050222126 - Roskelley, Calvin ;   et al.
2005-10-06
Integrin-linked kinase and its uses
App 20040106107 - Dedhar, Shoukat ;   et al.
2004-06-03
Integrin-linked kinase and its uses
Grant 6,699,983 - Dedhar , et al. March 2, 2
2004-03-02
Novel use of calreticulin in modulating hormone responsiveness and new pharmaceuticals for treating cancer, osteoporosis and chronic inflammatory disease
App 20030060613 - Dedhar, Shoukat
2003-03-27
Pharmaceuticals for modulating hormone responsiveness
Grant 6,518,397 - Dedhar February 11, 2
2003-02-11
Antiangiogenic compounds and an assay for inhibitors of cell invasion
App 20030004149 - Roskelley, Calvin ;   et al.
2003-01-02
Treatment of inflammatory diseases including psoriasis
App 20020155179 - Dedhar, Shoukat ;   et al.
2002-10-24
Integrin-linked kinase and its uses
App 20020122801 - Dedhar, Shoukat ;   et al.
2002-09-05
Integrin-linked kinase and its use
App 20020107216 - Dedhar, Shoukat ;   et al.
2002-08-08
Integrin-linked kinase and its use
Grant 6,001,622 - Dedhar , et al. December 14, 1
1999-12-14
Peptide fragments of calreticulin, peptide mimetics thereof, and pharmaceutical compostions comprising same
Grant 5,854,202 - Dedhar December 29, 1
1998-12-29
Company Registrations

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed